Analysis of the domestic market of plant-based medicines

Authors

  • E. V. Tolochko National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/nphj.15.2058

Keywords:

pharmaceutical market, analysis, medicines, herbal remedies

Abstract

 

Therapy with medicinal plants and remedies on their basis from time immemorial has been used by mankind to treat a variety of diseases and has not lost its relevance up to now. Today, phytomedicines are used both in the complex therapy (as a complementary element) and independently. There are medicines of the plant origin and herbal remedies. The aim of this study was to analyse the range of phytomedicines registered at the pharmaceutical market of Ukraine. In the section “Herbal medicines” of Reference book of medicines of Ukraine (04/01/2013) 992 names of medicines are presented, except of substances and medicines in bulk. The study of this range has shown that the vast majority of medicines are manufactured in Ukraine. Medicines produced in Germany and India prevail among foreign phytomedicines. Subsequent analysis of dosage forms of phytomedicines has revealed that the largest number of medicines comes to the domestic market in the form of the medicinal plant raw material, tablets, tinctures, capsules, solutions and syrups. Distribution of phytomedicines by the age limits has been studied. It has been found that the most of medicines are intended for use by children above 12 years old and adults. Thus, it has been found that there are only few phytomedicines for younger children, whereas phytotherapy is the most appropriate for treating children of different age groups. This fact makes developing of new domestic phytomedicines for use in pediatrics particularly relevant and reasonable.


Author Biography

E. V. Tolochko, National University of Pharmacy

Ассистент кафедры технологии лекарств

References

Герасименко С.С., Головач А.В., Єріна А.М. та ін. Статистика: Підруч.; За наук. ред.. С.С. Герасименка. – 2-ге вид., перероб. і доп. – К.: КНЕУ, 2000. – 467 с.

Довідник лікарських засобів України (01.04.2013) [Електронний ресурс] : МОЗ України Деп. фар мац. діяльності. — К.: CD-вид-во "Iнфодиск", 2004. — 1 електрон. опт. диск (CD-ROM) : кольор. ; 12 см. — (Довідник лікарських засобів України (01.04.2013). — Систем. вимоги: ЦП: 1 Гц чи потужніший; Оперативна пам'ять: 64 Мб і більше; Відеокарта: VGA і вище. — Назва з титул. екрану.

Фітотерапевтичні засоби та фітопрепарати для загальної лікарської практики : навч. посібник / В. Г. Лизогуб, В. П. Лисенюк, М. І. Наумова. – К., 2007. – 98 с.

Фитотерапия: учеб. пособие для студ. высш. мед. учеб. заведений / С. Н. Турищев. – М. : Изд. центр «Академия», 2003. –304 с.

Фітотерапія: навч. посібник / Л. В. Андріюк та ін.; за заг. ред. Л.В. Андріюка, Т.П. Гарник. – Львів: Вид-во «Папуга», 2013. – 166 с.

Шелепко С. [Електронний ресурс] // Аптека. – 2014. - № 966 (45). – Режим доступу до журн.: http://www.apteka.ua/article/313335

Izzo A.A., Ernst E. // Drugs. – 2009. – Vol. 69, № 13. – P. 1777 – 1798.

Rivera J.O., Ortiz M., González-Stuart A., Hughes H. // J. Herb. Pharmacother. – 2007. – Vol. 7, № 3-4. – P. 91 – 106.

Sharp V. J., Takacs E. B., Powell C. R. // American family physician. – 2010. – Vol. 82, № 4. – P. 397–406.

Tian S. [Електронний ресурс] // Health Guidance. – 2013. – Режим доступу до журн.: http://www.healthguidance.org/entry/12415/1/Advantages-and-Disadvantages-of-Herbal-Medicine.html

Downloads

Published

2015-09-11

Issue

No. 3(83) (2015)

Section

Organization and Economy of Pharmacy

License

Copyright (c) 2015 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).